Evidence map›Paper›PMID 18662700›Full record

ArticleJournal of molecular biology2008

The positive transcription elongation factor b is an essential cofactor for the activation of transcription by myocyte enhancer factor 2.

Masanori Nojima, Yehong Huang, Mudit Tyagi, Hung-Ying Kao, Koh Fujinaga

Abstract read
In one paragraph

Article in Journal of molecular biology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. CDK9 keeps RNA polymerase II on track.Cellular and molecular life sciences : CMLS · 2021
    Review
  3. Review
  4. P-TEFb as A Promising Therapeutic Target.Molecules (Basel, Switzerland) · 2020
    Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. P-TEFb- the final frontier.Cell division · 2009
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Masanori NojimaDivision of Infectious Diseases, Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
Yehong Huang
Mudit Tyagi
Hung-Ying Kao
Koh Fujinaga
University School · USCase Western Reserve University · US

Funding

Regulation of histone deacetylase 7 (HDAC7) activityR01DK062985 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI KAO, HUNG-YING · 2003 to 2006
$998k
NIDDK NIH HHS R01 DK062985NIDDK NIH HHS R01 DK62985
6 · The paper itself

Abstract

The positive transcription elongation factor b (P-TEFb), composed of cyclin-dependent kinase 9 and cyclin T1, stimulates the elongation of transcription by hyperphosphorylating the C-terminal region of RNA polymerase II. Aberrant activation of P-TEFb results in manifestations of cardiac hypertrophy in mice, suggesting that P-TEFb is an essential factor for cardiac myocyte function and development. Here, we present evidence that P-TEFb selectively activates transcription mediated by the myocyte enhancer factor 2 (MEF2) family of transcription factors, key regulatory factors for myocyte development. Knockdown of endogenous cyclin T1 in murine C2C12 cells abolishes MEF2-dependent reporter gene expression as well as transcription of endogenous MEF2 target genes, whereas overexpression of P-TEFb enhances MEF2-dependent transcription. P-TEFb interacts with MEF2 both in vitro and in vivo. Activation of MEF2-dependent transcription induced by serum starvation is mediated by a rapid dissociation of P-TEFb from its inhibitory subunit, HEXIM1, and a subsequent recruitment of P-TEFb to MEF2 binding sites in the promoter region of MEF2 target genes. These results indicate that recruitment of P-TEFb is a critical step for stimulation of MEF2-dependent transcription, therefore providing a fundamentally important regulatory mechanism underlying the transcriptional program in muscle cells.

Indexed as

Gene Expression RegulationTranscription, GeneticAnimalsCells, CulturedCyclin-Dependent Kinase 9CyclinsCyclin TDNA-Binding ProteinsGenes, ReporterGlucose Transporter Type 4HeLa CellsHumansJNK Mitogen-Activated Protein KinasesMEF2 Transcription FactorsMiceMuscle CellsCCNT1 protein, humanCDK9 protein, humanCyclin-Dependent Kinase 9CyclinsCyclin TDNA-Binding ProteinsGlucose Transporter Type 4Hexim1 protein, mouseJNK Mitogen-Activated Protein KinasesMEF2 Transcription FactorsMyogenic Regulatory FactorsNR4A1 protein, humanNr4a1 protein, mouseNr4a1 protein, ratNuclear Receptor Subfamily 4, Group A, Member 1Positive Transcriptional Elongation Factor BReceptors, SteroidRNA-Binding ProteinsRNA, Small InterferingTranscription Factors

Identifiers

PMID18662700
PMCPMC4118929
OpenAlexW1980787813

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.